Two people can share the same birthday and have profoundly different physiological profiles. One may carry the cellular and metabolic signatures of someone a decade younger; the other may show markers consistent with significant biological wear. Chronological age counts calendar years. Biological age attempts to measure something more meaningful: how your body is actually functioning at a cellular and systemic level, and how that compares to population norms for your age group.
How biological age is measured
The most discussed tools in biological age research are epigenetic clocks. These algorithms analyse patterns of DNA methylation, chemical tags on the genome that shift in predictable ways as cells age. Steve Horvath’s clock, published in 2013 in Genome Biology, was among the first to demonstrate that methylation patterns across hundreds of genomic sites correlate strongly with chronological age across diverse tissue types. More recent iterations, such as GrimAge and PhenoAge, go further by incorporating clinical biomarkers and linking methylation patterns to mortality risk rather than age alone.
Telomere length is another commonly cited biological age marker. Telomeres are protective caps on chromosomes that shorten with each cell division. Shorter telomeres are associated with cellular senescence and have been linked to age-related disease in observational research, though telomere length is highly variable between individuals and is not used in isolation as a reliable measure.
Metabolic markers add another layer. Fasting glucose, insulin sensitivity, lipid profiles, and markers of liver function reflect how efficiently your body is processing energy and managing systemic load. Inflammatory markers, particularly high-sensitivity C-reactive protein and interleukin-6, have featured in longevity research as indicators of low-grade chronic inflammation, which is increasingly understood as a driver of biological ageing rather than simply a consequence of it.
What accelerates biological ageing
Sustained metabolic dysfunction is among the most well-documented accelerants. Insulin resistance, visceral adiposity, and dyslipidaemia are consistently associated with accelerated epigenetic ageing in population studies. The mechanisms involve chronic oxidative stress, mitochondrial dysfunction, and the inflammatory signalling that follows.
Sleep deprivation has measurable effects on biological age markers. Research published in journals including Nature Communications has linked short sleep duration and poor sleep quality to accelerated DNA methylation ageing. Chronic psychological stress produces similar patterns, with elevated cortisol contributing to systemic inflammation and disrupted cellular repair processes.
Sedentary behaviour, highly processed dietary patterns, and smoking are all associated with accelerated biological ageing in the epidemiological literature. The common thread is sustained cellular stress without adequate recovery, repair, and resolution.
What the research shows can slow it
The evidence base for slowing biological ageing is more developed in some areas than others. Regular physical activity, particularly combinations of aerobic and resistance training, consistently associates with favourable biological age markers in observational and interventional research. The mechanisms are reasonably well understood: exercise stimulates mitochondrial biogenesis, reduces inflammatory signalling, and supports metabolic regulation.
Dietary quality, particularly patterns characterised by adequate protein, micronutrient density, and limited ultra-processed food, shows associations with slower biological ageing across multiple study designs. The Mediterranean dietary pattern has been studied in this context with reasonably consistent findings, though causality is difficult to isolate.
Sleep optimisation, stress management, and maintaining healthy metabolic markers round out what the current evidence most reliably supports. A range of pharmaceutical and nutraceutical interventions are being actively studied in longevity research, including compounds that target cellular senescence and mitochondrial function. The science in this area is developing. Some findings are promising; few are yet definitive at the level of clinical recommendation.
What a clinical assessment adds
Population-level research tells you what associates with slower biological ageing. A clinical assessment tells you where you currently sit and what is most relevant to your individual profile.
Establishing a baseline across relevant biomarkers, including metabolic, inflammatory, and hormonal markers, gives you a reference point. Repeat testing over time allows you to track whether lifestyle changes or clinical interventions are producing measurable shifts. It also surfaces factors that are not visible from the outside: insulin resistance can be well advanced before symptoms appear; inflammatory markers can be elevated without obvious cause.
The value of measurement is not anxiety about numbers. It is the ability to make decisions based on your actual biology rather than assumptions about what your age means for your health.
Biological age research is still maturing. The markers we have are informative, not definitive. But understanding where your body is functioning relative to your chronological age, and what factors are driving that picture, is a more useful starting point for health decisions than age alone.